Utama › Kanser Pankreas › Oklahoma › Oklahoma City
Kajian klinikal Kanser Pankreas di Oklahoma City, OK
11 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Oklahoma City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Mengambil pesertaFasa 3
- Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- University of Oklahoma, Oklahoma City
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Mengambil pesertaKajian pemerhatian
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Mengambil pesertaFasa 2
- Hightower Clinical, Oklahoma City
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Mengambil pesertaKajian pemerhatian
- University of Oklahoma, Oklahoma City
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Mengambil pesertaFasa 2
- Ohio State University-Telemedicine, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #13, Oklahoma City
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Arlington, VA33 kajian
- Baltimore, MD31 kajian
- San Antonio, TX31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
Kajian lain di Oklahoma City
- Kanser Paru-paru Bukan Sel Kecil28 kajian
- Kanser Ovari28 kajian
- Kanser Endometrium25 kajian
- Kanser Kolorektal22 kajian
- Kanser Prostat21 kajian
- Kanser Paru-paru19 kajian
- Kanser Payudara17 kajian
- Kanser Metastatik16 kajian
- Kanser (semua jenis)14 kajian
- Leukemia Mieloid Akut14 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher13 kajian
- Kanser Pundi Kencing11 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.